Skip to ContentGo to accessibility pageKeyboard shortcuts menu
OpenStax Logo

Unfolding Case Study

1.
c. The client is presenting with signs and symptoms of edema—weight gain and peripheral edema.
2.
d. A chemistry panel measures key electrolytes and renal function tests.
3.
b. Anuria is a contraindication to diuretic administration. Accordingly, decreasing urine output should be reported to the health care provider because it could indicate that the client’s renal function is deteriorating.
4.
b. Nonpharmacologic treatment for edema includes a low-sodium diet, walking, and elevating extremities to reduce swelling.
5.
a. Green, leafy vegetables are an important part of a low-sodium diet with potassium-rich foods. This statement indicates a need for further teaching.
6.
c. Thiazide diuretics can cause hypokalemia, which can cause changes in heart rate and rhythm.

Review Questions

1.
c. The diuretic effect of furosemide can cause electrolyte abnormalities such as hyponatremia and hypokalemia, which cause weakness.
2.
d. Amiloride is a potassium-sparing diuretic, so salt substitutes containing potassium should be avoided.
3.
c. An eGFR value less than 60 mL/minute/1.73 m2 for 3 months indicates chronic renal disease.
4.
b. Mannitol is an osmotic diuretic that creates an osmotic gradient that pulls water from cells into the intravascular space.
5.
b. Thiazide diuretics such as hydrochlorothiazide maintain serum calcium levels.
6.
a. Mannitol is contraindicated for clients with heart failure. Lung congestion and peripheral edema are signs of this condition for which the nurse needs to monitor.
7.
d. Clients taking spironolactone are at risk for developing bradycardia.
8.
a. The nurse should instruct the client to take diuretics in the morning to help prevent nocturia.
9.
d. Loop diuretics cause potassium to be excreted and can be used for clients with hyperkalemia.
10.
b. Diuretics such as furosemide have a threshold dose that is required for response, as well as a ceiling dose beyond which the diuretic effect will not increase.
Citation/Attribution

This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's permission.

Want to cite, share, or modify this book? This book uses the Creative Commons Attribution License and you must attribute OpenStax.

Attribution information
  • If you are redistributing all or part of this book in a print format, then you must include on every physical page the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
  • If you are redistributing all or part of this book in a digital format, then you must include on every digital page view the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
Citation information

© May 15, 2024 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution License . The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.